光加重性特应性皮炎的临床与光生物学特征分析
这项病例系列研究在2015年1月至2019年10月连续纳入120例光加重性特应性皮炎(PAD)患者,分析其标准化临床与光生物学资料。结果显示PAD占光检查患者的14%,多数为成人,生活质量显著受损,光激发试验阳性率高。作者认为光测试有助于识别诱发波长、光接触过敏并给出个体化光防护建议。
要点
- 光加重性特应性皮炎占光检查患者的14%(120/869),其中成人占87%(104/120)。
- 80/103名成人(78%)既往一年皮肤病生活质量指数大于10分。
- 宽谱紫外线激发试验阳性112例(93%),光斑贴试验阳性18例(15%)。
核心结论
- 光加重性特应性皮炎累及不同年龄和皮肤光型患者,并与生活质量显著受损相关。
- 作者认为通过光测试确认光加重性特应性皮炎可识别诱发波长、相关光接触过敏并提供适当光防护建议,从而为患者提供更好的个体化照护。
研究设计与样本
- 病例系列研究,采用横断面数据,连续纳入2015年1月至2019年10月某三级中心光生物学转诊单位的120例光加重性特应性皮炎患者。
- 分析常规收集的标准化临床与光生物学资料,使用描述性统计和回归分析探讨人口学与临床数据间的关联。
主要发现
- 869例接受光检查的患者中120例(14%)诊断为光加重性特应性皮炎,其中女性69例(58%),中位年龄45岁(IQR 31-61岁),范围5-83岁,皮肤光型I-VI。
- 120例中成人104例(87%),所有患者均有特应性皮炎病史,104例中62例(60%)表现为日光诱发或光分布性湿疹,光敏感发生中位年龄37岁(范围1-72岁)。
- 103名成人中80例(78%)既往一年皮肤病生活质量指数大于10分,119例中82例(69%)维生素D(25-羟基维生素D)水平不足或缺乏(<20 ng/mL)。
- 宽谱紫外线激发试验阳性112例(93%);28例(23%)单色光测试异常,对UV-A、UV-B和/或可见光敏感,350 ± 10 nm的UV-A为最常见波长;光斑贴试验阳性18例(15%)。
- 皮肤光型V-VI组31例(26%)与I-IV组89例(74%)相比,光敏感发生中位年龄更小(24岁[IQR 15-37岁] vs 40岁[IQR 25-55岁];P = .003),女性比例更高(23例[74%] vs 46例[52%];P = .03),维生素D水平更低且单色光测试异常频率更高。
关键数值与推荐
- 光加重性特应性皮炎在光检查患者中占14%(120/869)。
- 宽谱紫外线激发试验阳性率为93%(112/120)。
- 光斑贴试验阳性率为15%(18/120)。
- 维生素D不足或缺乏(<20 ng/mL)占69%(82/119)。
- 皮肤病生活质量指数大于10分占成人78%(80/103)。
临床怎么用
- 作者认为通过光测试确认光加重性特应性皮炎可识别诱发波长、相关光接触过敏并提供适当光防护建议,从而为患者提供更好的个体化照护。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Photoaggravated atopic dermatitis (PAD) is estimated to affect 1.4% to 16% of patients with AD but remains poorly characterized with limited published data. OBJECTIVE: To provide detailed clinical and photobiological characterization of PAD. DESIGN, SETTING, AND PARTICIPANTS: This case series study used cross-sectional data collected from 120 consecutive patients diagnosed with PAD from January 2015 to October 2019 at a tertiary center referral unit for photobiology. MAIN OUTCOMES AND MEASURES: Routinely collected standardized clinical and photobiological data were analyzed using descriptive statistics, and regression analysis explored associations between demographic and clinical data. RESULTS: Of 869 patients who underwent photoinvestigation, 120 (14%) were diagnosed with PAD (69 female [58%]; median age, 45 [IQR, 31-61] years; range, 5-83 years; skin phototypes [SPTs] I-VI). Of these patients, 104 (87%) were adults. All patients had a history of AD, and most (62 of 104 [60%]) presented with sunlight-provoked or photodistributed eczema; median age at photosensitivity onset was 37 years (range, 1-72 years). Past-year Dermatology Life Quality Index score was greater than 10 for 80 of 103 adults (78%), and 82 of 119 (69%) had vitamin D (25-hydroxyvitamin D) level insufficiency or deficiency (<20 ng/mL; to convert ng/mL to nmol/L, multiply by 2.496). Broadband UV radiation provocation test results were positive for 112 patients (93%). In 28 patients (23%) with abnormal monochromator phototest findings, sensitivity occurred to UV-A, UV-B, and/or visible light, and UV-A of 350 ± 10 nm was the most prevalent wavelength. Photopatch test reactions were positive for 18 patients (15%). Patients with SPTs V to VI (31 [26%]) vs SPTs I to IV (89 [74%]) were younger at photosensitivity onset (median age, 24 years [IQR, 15-37 years] vs 40 years [IQR, 25-55 years]; P = .003), were more likely to be female (23 [74%] vs 46 [52%]; P = .03), and had a lower vitamin D status and a higher frequency of abnormal monochromator phototest findings. CONCLUSIONS AND RELEVANCE: In this case series study, PAD affected patients with different ages and SPTs and was associated with substantially impaired quality of life. The findings suggest that confirming PAD through phototesting may provide better personalized care for patients through identification of provoking wavelengths, relevant photocontact allergies, and appropriate photoprotection advice.
引用
- Rutter KJ, Farrar MD, Marjanovic EJ, et al. Clinicophotobiological Characterization of Photoaggravated Atopic Dermatitis. JAMA Dermatol. 2022. PMID: 35895040. doi:10.1001/jamadermatol.2022.2823
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。